{
  "content": "Diagnosis:\t\tRight breast apocrine carcinoma\n\nStage:\t\tT3N3M0 (Stage IIIC)\n\nBiomarkers:\tAR positive, ER/PR negative, HER2 positive (3+)\n\nTreatment:\t\t12 Jan 2024 Right mastectomy and axillary clearance\n\t\t\t1 Feb - 15 Mar 2024 Adjuvant chemotherapy (6 cycles docetaxel/carboplatin/trastuzumab)\n\t\t\t20 Mar - 30 Apr 2024 Adjuvant radiotherapy completed\n\nCurrent Status:\tEnd of treatment review\n\n[redacted name] has completed her planned adjuvant treatment for right breast cancer. She tolerated the chemotherapy well with only grade 1 fatigue and minimal neuropathy. Radiotherapy was completed with expected grade 1 skin reaction which has now resolved. Her surgical site has healed well with good shoulder mobility. Performance status remains 0.\n\nShe will continue single agent trastuzumab to complete 12 months of treatment. Next dose due in 2 weeks. Mammogram of the contralateral breast and CT scan arranged for 3 months' time as baseline post-treatment imaging. Will review in clinic with results.",
  "output": {
    "primary_cancer": {
      "site": "breast, right",
      "year": 2024,
      "month": 1,
      "metastases": "axillary nodal involvement",
      "tnm_stage": "T3N3M0",
      "other_stage": "Stage IIIC",
      "histopathology_status": "apocrine carcinoma",
      "biomarker_status": "AR positive, ER/PR negative, HER2 positive (3+)",
      "cancer_timeline": [
        {
          "type": "treatment_surgery",
          "value": "Right mastectomy and axillary clearance",
          "year": 2024,
          "month": 1
        },
        {
          "type": "treatment_systemic_start",
          "value": "Started adjuvant docetaxel/carboplatin/trastuzumab chemotherapy",
          "year": 2024,
          "month": 2
        },
        {
          "type": "treatment_systemic_change",
          "value": "Completed 6 cycles of docetaxel/carboplatin/trastuzumab",
          "year": 2024,
          "month": 3
        },
        {
          "type": "treatment_radiotherapy",
          "value": "Completed course of adjuvant radiotherapy",
          "year": 2024,
          "month": 4
        }
      ]
    },
    "patient_facts": [
      {
        "type": "performance_status",
        "value": "Performance status 0"
      },
      {
        "type": "current_symptom",
        "value": "Grade 1 fatigue and minimal neuropathy from chemotherapy"
      },
      {
        "type": "examination_finding",
        "value": "Well-healed surgical site with good shoulder mobility"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Stage IIIC right breast apocrine carcinoma. Completed planned surgery, chemotherapy and radiotherapy with good tolerance"
      },
      {
        "type": "latest_treatment_toxicity",
        "value": "Grade 1 skin reaction from radiotherapy, now resolved"
      },
      {
        "type": "update_to_treatment",
        "value": "To continue single agent trastuzumab to complete 12 months of treatment"
      },
      {
        "type": "planned_investigation",
        "value": "Mammogram of contralateral breast and CT scan in 3 months for post-treatment baseline"
      },
      {
        "type": "follow_up_referral",
        "value": "Clinical review when imaging results available"
      }
    ]
  }
}